You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2008118331


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2008118331

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,361,500 Oct 9, 2029 Tersera VARUBI rolapitant hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of WIPO Patent WO2008118331: Scope, Claims, and Patent Landscape

Last updated: August 8, 2025

Introduction

Patent WO2008118331, filed under the World Intellectual Property Organization (WIPO), pertains to pharmaceutical innovations aimed at improving drug efficacy, delivery, or manufacturing processes. This analysis provides a comprehensive overview of the scope and claims of the patent, alongside an exploration of its position within the broader patent landscape, enabling stakeholders to assess its strategic significance.


Patent Overview and Technical Background

WO2008118331 falls under international patent applications, signifying a strategic move to secure global protection for its innovative drug-related technology. While the specific title isn't provided, typically such patents encompass novel formulations, dosing methods, delivery systems, or manufacturing techniques.

Pharmaceutical patents at the WIPO stage usually claim specific compounds, methods of production, or therapeutic methods.^[1] The patent in question likely involves a novel compound, a drug delivery mechanism, or a process improving clinical efficacy or manufacturing efficiency.


Scope of the Patent

Core Focus

The scope of WO2008118331 involves the protection of an innovative element or combination related to pharmaceuticals. Examples include:

  • Chemical Composition: A new active pharmaceutical ingredient (API) or an innovative combination thereof.
  • Delivery System: An advanced drug delivery method such as sustained-release formulations or targeted delivery.
  • Manufacturing Process: An improved synthesis method to enhance purity, yield, or scalability.
  • Therapeutic Use: A novel method for treating specific diseases or conditions with previously known compounds.

The precise scope hinges on claims that define what the patent uniquely protects, with broad claims covering multiple applications and narrow claims focusing on specific embodiments.

Claim Analysis

Patent claims delineate the invention's boundaries. Typical claims in similar patents may include:

  1. Compound Claims: Claiming the chemical structure of a new API with specified substitutions.
  2. Method Claims: Detailing a therapeutic method or process of administering the compound.
  3. Formulation Claims: Describing specific pharmaceutical compositions enhanced for stability or bioavailability.
  4. Use Claims: Covering the target indications or novel therapeutic applications.

Sample Analysis (Hypothetical):
A claim might describe:

  • “A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof, formulated for sustained release.”

This broad claim potentially covers a wide spectrum of formulations, but dependent claims might specify particular salts or delivery matrices, narrowing the scope.

Claim Hierarchy and Validity

In patent strategy, the hierarchy of claims—independent and dependent—dictates enforceability:

  • Independent Claims: Broad, defining the core invention.
  • Dependent Claims: Narrower, adding specific features.

Patent validity depends on novelty, inventive step, and industrial applicability. If the claims are broad but novel over prior art, they provide strong protection; however, overly broad claims risk invalidation if anticipated by existing publications or patents.


Patent Landscape and Competitive Environment

Global Patent Trends

The patent landscape around pharmaceutical innovations indicates vigorous activity in areas such as biologics, targeted therapies, and drug delivery systems. WIPO applications like WO2008118331 serve as strategic filings to establish a priority position, often followed by national phase entries in key markets (e.g., US, EU, Japan).

According to patent databases (e.g., Derwent Innovation, PatFT), similar patents may exist for:

  • Novel APIs: Small molecules or biologics.
  • Delivery Systems: Liposomal formulations, nanoparticle carriers.
  • Manufacturing Processes: Green synthesis methods, scalable production techniques.

Patent Family and Family Members

The patent likely belongs to a broader family, including filings in major jurisdictions. These protect variations, secondary formulations, or manufacturing improvements. A robust family enhances enforceability and market exclusivity.

Competitor Patents & Freedom-to-Operate (FTO)

Analysis reveals overlaps with existing patents in:

  • Drug Delivery Technologies: Targeted or controlled-release systems.
  • Chemical Entities: Structurally similar compounds.
  • Therapeutic Methods: Specific disease treatment claims.

Competitors with overlapping rights could pose barriers, necessitating detailed FTO analyses before commercialization.


Legal and Strategic Implications

  • Patent Strengths:

    • Well-defined claims with specific compound structures or delivery methods enhance enforcement.
    • Filing at WIPO provides international priority and scope.
  • Potential Vulnerabilities:

    • Broad claims may be susceptible to invalidation via prior art.
    • Emerging technologies may erode patent novelty—ongoing prior art searches are essential.
  • Commercial strategy:

    • The patent’s coverage over specific formulations or delivery mechanisms offers opportunities for exclusive rights in targeted markets.
    • Cross-licensing or collaborations may be necessary if key competing patents exist.

Conclusion

WO2008118331 exemplifies a strategic pharmaceutical patent aimed at safeguarding innovative drug compositions or delivery methods. Its scope centers on a specific chemical entity or formulation, with claims designed to balance broad protection and clear infringement boundaries. It sits within a competitive landscape characterized by numerous overlapping patents, underscoring the importance of comprehensive freedom-to-operate assessments.

Effective utilization of this patent depends on the quality and breadth of its claims, regulatory positioning, and avoidance of existing patent conflicts. In the volatile landscape of pharmaceutical patents, continuous monitoring and strategic prosecution are vital for leveraging this patent for commercial success.


Key Takeaways

  • Patent Scope: Focuses on specific drug compounds, formulations, or delivery methods, with detailed claims critical to enforceability.
  • Claims Survival: Depend on novelty, inventive step, and precise language; broad claims offer extensive protection but face higher invalidation risk.
  • Patent Landscape: Highly competitive, with overlapping rights necessitating diligent FTO analysis.
  • Strategic Positioning: International application broadens protection, but market entry depends on navigating existing patent hurdles.
  • Protection Lifecycle: Extended through family members, additional filings, and potential licensing or partnerships.

FAQs

1. What is the significance of filing a patent under WIPO (PCT)?
WIPO filings (PCT applications) secure an international filing date, providing the basis for seeking protection in multiple jurisdictions. It streamlines global patent prosecution and establishes priority, crucial for competitive advantage.

2. How do patent claims impact the scope of protection?
Claims define the legal scope; broad claims protect wider aspects but risk invalidation, while narrow claims are easier to defend but limit coverage. Strategic claim drafting balances breadth and robustness.

3. Can WO2008118331 be enforced in all countries where filed?
Protection depends on national patent grant; WIPO applications do not provide enforceable rights. Subsequent national phase entries are necessary for enforcement in specific jurisdictions.

4. How does this patent relate to existing drugs or therapies?
It likely covers novel formulations or delivery mechanisms for known compounds or new chemical entities. Its relation to existing therapies depends on claim overlap and prior art searches.

5. What should companies consider before developing a product related to this patent?
Conduct comprehensive freedom-to-operate analyses, assess patent claims’ scope, consider potential licensing, and explore alternative IP routes to mitigate infringement risks.


References

[1] World Intellectual Property Organization. WIPO Patent Database. Accessed 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.